"Thrombotic Microangiopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.
Below are MeSH descriptors whose meaning is more general than "Thrombotic Microangiopathies".
Below are MeSH descriptors whose meaning is more specific than "Thrombotic Microangiopathies".
This graph shows the total number of publications written about "Thrombotic Microangiopathies" by people in this website by year, and whether "Thrombotic Microangiopathies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Thrombotic Microangiopathies" by people in Profiles.
C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy. Bone Marrow Transplant. 2022 09; 57(9):1445-1447.
Severe COVID-19: A multifaceted viral vasculopathy syndrome. Ann Diagn Pathol. 2021 Feb; 50:151645.
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol. 2020 10; 16(10):581-589.
Drug-induced thrombotic microangiopathy: An updated systematic review, 2014-2018. Am J Hematol. 2018 09; 93(9):E241-E243.
Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies. Bone Marrow Transplant. 2018 02; 53(2):129-137.
Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients. Am J Kidney Dis. 2017 Nov; 70(5):686-695.
After the Party's Over. N Engl J Med. 2017 Jan 05; 376(1):74-80.
Interferon-induced thrombotic microangiopathy. Blood. 2016 12 15; 128(24):2753-2754.
Long-term outcomes of health-related quality of life following diverse thrombotic microangiopathy syndromes. Am J Hematol. 2016 Jun; 91(4):E278-9.
Cobalamin C deficiency-associated thrombotic microangiopathy: uncommon or unrecognised? Lancet. 2015 Sep 05; 386(9997):1012.